In humans, loss of function mutations in MFN2 and OPA1 genes cause the neurodegenerative diseases, Charcot–Marie–Tooth type 2A (CMT2A) [49] and dominant optic atrophy (DOA) [50,51], respectively. Here, OPA1 is linked to autosomal dominant optic atrophy.